2025

1. Activity of imipenem-relebactam, ceftolozane-tazobactam and comparators against clinical isolates of Enterobacterales and Pseudomonas aeruginosa causing severe infections in hematological and oncological patients: A prospective multicenter study

   International Journal of Antimicrobial Agents, Vol. 66, Núm. 3

2. Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trial

   Heart, Vol. 111, Núm. 24, pp. 1191-1198

3. Automatic Detection of Vegetations With Transesophageal Echocardiography in Infective Endocarditis Using Artificial Intelligence

   Journal of Imaging Informatics in Medicine

4. Clinical utility and safety of finerenone in patients with heart failure: Rationale and design of FINE registry

   ESC Heart Failure, Vol. 12, Núm. 4, pp. 3163-3172

5. Consensus document for Severe Asthma. 2025 Update

   Open Respiratory Archives, Vol. 7, Núm. 4

6. Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation

   The New England journal of medicine, Vol. 392, Núm. 14, pp. 1396-1405

7. Differential effect of triglycerides on the prognosis of patients with a first versus recurrent acute coronary syndrome

   European Journal of Clinical Investigation, Vol. 55, Núm. 10

8. Effect of Dapagliflozin on Quality of Life of Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

   Journal of the American College of Cardiology, Vol. 86, Núm. 15, pp. 1128-1138

9. Effect of Volume on Postoperative Outcomes After Left Pancreatectomy: A Multicenter Prospective Snapshot Study (SPANDISPAN Project)

   Journal of Clinical Medicine, Vol. 14, Núm. 17

10. Estimate and prognosis of patients who are candidates for treatment with eicosapentaenoic acid after an acute coronary syndrome

    Journal of Clinical Lipidology, Vol. 19, Núm. 4, pp. 827-834

11. Evaluation of carbohydrate antigen 125 in heart failure with preserved ejection fraction diagnosis

    Heart

12. Homozygous Familial Hypercholesterolemia in Spain: Data From Registry of the Spanish Atherosclerosis Society

    Journal of Clinical Endocrinology and Metabolism, Vol. 110, Núm. 8, pp. 2280-2287

13. Impact of gender on in-hospital and long-term outcomes after transcatheter aortic valve implantation: an analysis of the Spanish TAVI registry

    Revista Espanola de Cardiologia, Vol. 78, Núm. 4, pp. 338-346

14. Long-term outcomes of hydrodynamic ultra-thin strut sirolimus-eluting stent with fluoropolymer containing triflusal: VELAZQUEZ-EPIC26 study

    Cardiovascular Revascularization Medicine

15. Parkinson’s disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial

    npj Parkinson's Disease, Vol. 11, Núm. 1

16. Patient and Physician Perspectives on Cardiovascular Risk: A Multicenter Survey of Communication Gaps Among Hospitalized Patients in Spain

    Circulation. Cardiovascular quality and outcomes, Vol. 18, Núm. 10, pp. e011837

17. Rotational Atherectomy, Lithotripsy, or Laser for Calcified Coronary Stenosis: One-Year Outcomes From the ROLLER COASTER-EPIC22 Trial

    Catheterization and Cardiovascular Interventions, Vol. 106, Núm. 1, pp. 702-710

18. Rotational Atherectomy, Lithotripsy, or Laser for Calcified Coronary Stenosis: The ROLLER COASTR-EPIC22 Trial

    JACC: Cardiovascular Interventions, Vol. 18, Núm. 5, pp. 606-618

19. SEOM–SOGUG clinical guideline for urothelial cancer (2025)

    Clinical and Translational Oncology, Vol. 27, Núm. 11, pp. 4142-4159

20. Surgical approach and postoperative outcomes after left pancreatectomy (SPANDISPAN prospective project)

    Cirugia Espanola, Vol. 103, Núm. 9